164 related articles for article (PubMed ID: 38383671)
1. Elevated serum levels of leukocyte cell-derived chemotaxin 2 are associated with the prevalence of metabolic syndrome.
Zheng X; Lu J; Xiang S; Zou P; Chen H; Liu J; Zeng C; He Y
Acta Diabetol; 2024 May; 61(5):643-655. PubMed ID: 38383671
[TBL] [Abstract][Full Text] [Related]
2. Elevated Serum Cyclophilin B Levels Are Associated with the Prevalence and Severity of Metabolic Syndrome.
Zhang H; Fan Q; Xie H; Lu L; Tao R; Wang F; Xi R; Hu J; Chen Q; Shen W; Zhang R; Yan X
Front Endocrinol (Lausanne); 2017; 8():360. PubMed ID: 29312150
[TBL] [Abstract][Full Text] [Related]
3. Association of leukocyte cell-derived chemotaxin 2 (LECT2) with NAFLD, metabolic syndrome, and atherosclerosis.
Yoo HJ; Hwang SY; Choi JH; Lee HJ; Chung HS; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
PLoS One; 2017; 12(4):e0174717. PubMed ID: 28376109
[TBL] [Abstract][Full Text] [Related]
4. Increased serum leukocyte cell-derived chemotaxin 2 (LECT2) levels in obesity and fatty liver.
Okumura A; Unoki-Kubota H; Matsushita Y; Shiga T; Moriyoshi Y; Yamagoe S; Kaburagi Y
Biosci Trends; 2013 Dec; 7(6):276-83. PubMed ID: 24390366
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte cell-derived chemotaxin 2 promotes the development of nonalcoholic fatty liver disease through STAT-1 pathway in mice.
Wang J; Chen Y; Pan R; Wu C; Chen S; Li L; Li Y; Yu C; Meng ZX; Xu C
Liver Int; 2021 Apr; 41(4):777-787. PubMed ID: 33555112
[TBL] [Abstract][Full Text] [Related]
6. Associations Between Serum Uric Acid Concentrations and Cardiometabolic Risk and Renal Injury in Obese and Overweight Children.
Özalp Kızılay D; Şen S; Ersoy B
J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):262-269. PubMed ID: 30759960
[TBL] [Abstract][Full Text] [Related]
7. Rapid response of the steatosis-sensing hepatokine LECT2 during diet-induced weight cycling in mice.
Chikamoto K; Misu H; Takayama H; Kikuchi A; Ishii KA; Lan F; Takata N; Tajima-Shirasaki N; Takeshita Y; Tsugane H; Kaneko S; Matsugo S; Takamura T
Biochem Biophys Res Commun; 2016 Sep; 478(3):1310-6. PubMed ID: 27562717
[TBL] [Abstract][Full Text] [Related]
8. Visceral fat area is a strong predictor of leukocyte cell-derived chemotaxin 2, a potential biomarker of dyslipidemia.
Tanisawa K; Taniguchi H; Sun X; Ito T; Kawakami R; Sakamoto S; Higuchi M
PLoS One; 2017; 12(3):e0173310. PubMed ID: 28278265
[TBL] [Abstract][Full Text] [Related]
9. Reduced serum level of leukocyte cell-derived chemotaxin 2 is associated with the presence of diabetic retinopathy.
Okumura A; Unoki-Kubota H; Yoshida-Hata N; Yamamoto-Honda R; Yamashita S; Iwata M; Tobe K; Kajio H; Noda M; Katai N; Yamagoe S; Kaburagi Y
Clin Chim Acta; 2016 Dec; 463():145-149. PubMed ID: 27816666
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and gallstone disease.
Chen LY; Qiao QH; Zhang SC; Chen YH; Chao GQ; Fang LZ
World J Gastroenterol; 2012 Aug; 18(31):4215-20. PubMed ID: 22919256
[TBL] [Abstract][Full Text] [Related]
11. Circulating LECT2 levels in newly diagnosed type 2 diabetes mellitus and their association with metabolic parameters: An observational study.
Zhang Z; Zeng H; Lin J; Hu Y; Yang R; Sun J; Chen R; Chen H
Medicine (Baltimore); 2018 Apr; 97(15):e0354. PubMed ID: 29642178
[TBL] [Abstract][Full Text] [Related]
12. Serum leukocyte cell-derived chemotaxin 2 level is associated with atopic dermatitis patients.
Zhao K; Xu F; Jiang X; Chen J; Zhu X; Zhou Q; Xu S
Ann Palliat Med; 2021 Oct; 10(10):11006-11012. PubMed ID: 34763463
[TBL] [Abstract][Full Text] [Related]
13. Fat distribution measurements by chemical shift-encoded transition region extraction predict the risk of hyperglycaemia, dyslipidaemia and metabolic syndrome in mice.
Wu HX; Lin X; Cheng CL; Jiang HL; Iqbal J; Liu J; Zhou HD
NMR Biomed; 2023 Oct; 36(10):e4985. PubMed ID: 37283179
[TBL] [Abstract][Full Text] [Related]
14. Associations between smoking, components of metabolic syndrome and lipoprotein particle size.
Slagter SN; van Vliet-Ostaptchouk JV; Vonk JM; Boezen HM; Dullaart RP; Kobold AC; Feskens EJ; van Beek AP; van der Klauw MM; Wolffenbuttel BH
BMC Med; 2013 Sep; 11():195. PubMed ID: 24228807
[TBL] [Abstract][Full Text] [Related]
15. Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.
Feng RN; Du SS; Wang C; Li YC; Liu LY; Guo FC; Sun CH
World J Gastroenterol; 2014 Dec; 20(47):17932-40. PubMed ID: 25548491
[TBL] [Abstract][Full Text] [Related]
16. Association between high-fasting insulin levels and metabolic syndrome in non-diabetic middle-aged and elderly populations: a community-based study in Taiwan.
Chen YH; Lee YC; Tsao YC; Lu MC; Chuang HH; Yeh WC; Tzeng IS; Chen JY
BMJ Open; 2018 May; 8(5):e016554. PubMed ID: 29724734
[TBL] [Abstract][Full Text] [Related]
17. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
Meis SB; Schuster D; Gaillard T; Osei K
Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
[TBL] [Abstract][Full Text] [Related]
18. LECT2 as a hepatokine links liver steatosis to inflammation via activating tissue macrophages in NASH.
Takata N; Ishii KA; Takayama H; Nagashimada M; Kamoshita K; Tanaka T; Kikuchi A; Takeshita Y; Matsumoto Y; Ota T; Yamamoto Y; Yamagoe S; Seki A; Sakai Y; Kaneko S; Takamura T
Sci Rep; 2021 Jan; 11(1):555. PubMed ID: 33436955
[TBL] [Abstract][Full Text] [Related]
19. Differential impact of serum glucose, triglycerides, and high-density lipoprotein cholesterol on cardiovascular risk factor burden in nondiabetic, obese African American women: implications for the prevalence of metabolic syndrome.
Gaillard T; Schuster D; Osei K
Metabolism; 2010 Aug; 59(8):1115-23. PubMed ID: 20051282
[TBL] [Abstract][Full Text] [Related]
20. Optimal cut-off for obesity and markers of metabolic syndrome for Ethiopian adults.
Sinaga M; Worku M; Yemane T; Tegene E; Wakayo T; Girma T; Lindstrom D; Belachew T
Nutr J; 2018 Nov; 17(1):109. PubMed ID: 30466421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
